Hills Bank & Trust Co. boosted its position in Pfizer Inc. (NYSE:PFE) by 131.2% during the fourth quarter, Holdings Channel reports. The institutional investor owned 48,174 shares of the biopharmaceutical company’s stock after buying an additional 27,341 shares during the period. Hills Bank & Trust Co.’s holdings in Pfizer were worth $1,745,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other large investors have also recently bought and sold shares of the stock. Mckinley Capital Management LLC Delaware purchased a new stake in shares of Pfizer during the 2nd quarter worth $103,000. Herndon Capital Management LLC purchased a new stake in shares of Pfizer during the 2nd quarter worth $120,000. Americafirst Capital Management LLC purchased a new stake in shares of Pfizer during the 3rd quarter worth $127,000. Oak Point Wealth Management purchased a new stake in shares of Pfizer during the 4th quarter worth $165,000. Finally, Lipe & Dalton boosted its position in shares of Pfizer by 6.9% during the 2nd quarter. Lipe & Dalton now owns 4,626 shares of the biopharmaceutical company’s stock worth $155,000 after purchasing an additional 300 shares in the last quarter. Hedge funds and other institutional investors own 71.41% of the company’s stock.
In related news, insider Charles H. Hill sold 42,393 shares of the business’s stock in a transaction dated Tuesday, March 6th. The shares were sold at an average price of $35.76, for a total value of $1,515,973.68. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director W Don Cornwell sold 1,758 shares of the business’s stock in a transaction dated Tuesday, February 27th. The shares were sold at an average price of $36.79, for a total transaction of $64,676.82. Following the completion of the transaction, the director now directly owns 1,000 shares of the company’s stock, valued at approximately $36,790. The disclosure for this sale can be found here. Insiders sold a total of 185,464 shares of company stock valued at $6,767,939 in the last three months. 0.06% of the stock is currently owned by corporate insiders.
Shares of Pfizer Inc. (NYSE:PFE) opened at $36.75 on Wednesday. Pfizer Inc. has a 1 year low of $31.67 and a 1 year high of $39.43. The company has a market cap of $218,770.00, a PE ratio of 21.00, a P/E/G ratio of 2.07 and a beta of 0.91. The company has a quick ratio of 1.10, a current ratio of 1.35 and a debt-to-equity ratio of 0.47.
Pfizer (NYSE:PFE) last announced its earnings results on Tuesday, January 30th. The biopharmaceutical company reported $0.62 earnings per share for the quarter, beating the consensus estimate of $0.56 by $0.06. Pfizer had a net margin of 40.55% and a return on equity of 25.21%. The firm had revenue of $13.70 billion during the quarter, compared to the consensus estimate of $13.67 billion. During the same quarter in the previous year, the company posted $0.47 EPS. The firm’s revenue for the quarter was up .6% on a year-over-year basis. analysts anticipate that Pfizer Inc. will post 2.95 earnings per share for the current fiscal year.
Pfizer declared that its Board of Directors has authorized a stock repurchase plan on Monday, December 18th that permits the company to repurchase $10.00 billion in shares. This repurchase authorization permits the biopharmaceutical company to buy shares of its stock through open market purchases. Shares repurchase plans are often a sign that the company’s management believes its stock is undervalued.
The company also recently announced a quarterly dividend, which was paid on Thursday, March 1st. Investors of record on Friday, February 2nd were paid a $0.34 dividend. This is an increase from Pfizer’s previous quarterly dividend of $0.32. The ex-dividend date was Thursday, February 1st. This represents a $1.36 annualized dividend and a yield of 3.70%. Pfizer’s payout ratio is presently 77.71%.
ILLEGAL ACTIVITY NOTICE: This report was first posted by Markets Daily and is the property of of Markets Daily. If you are accessing this report on another publication, it was stolen and reposted in violation of U.S. & international copyright laws. The correct version of this report can be read at https://www.themarketsdaily.com/2018/03/14/hills-bank-trust-co-has-1-75-million-position-in-pfizer-inc-pfe.html.
Pfizer Inc (Pfizer) is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development and manufacture of healthcare products. Its global portfolio includes medicines and vaccines, as well as consumer healthcare products. The Company manages its commercial operations through two business segments: Pfizer Innovative Health (IH) and Pfizer Essential Health (EH).
Want to see what other hedge funds are holding PFE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Pfizer Inc. (NYSE:PFE).
Receive News & Ratings for Pfizer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pfizer and related companies with MarketBeat.com's FREE daily email newsletter.